Testing effectiveness (Phase 2)Looking for participantsNCT07038382
What this trial is testing
Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With Rituximab Injection Versus Placebo in Patients With Active Glomerulonephritis
Who this might be right for
Membranous NephropathyLupus Nephritis (LN)
Shanghai Henlius Biotech 24